Cogent Biosciences COGT
NASDAQ COGT
$31.02 -0.57 (-1.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Selling, General & Administrative (2017 - 2026)

Updated

Cogent Biosciences (COGT) reported Selling, General & Administrative of $31.83 million for Q2 2026, up 137.9% from $13.38 million a year earlier and up 12.7% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Selling, General & Administrative (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cogent Biosciences' Selling, General & Administrative came in at $98.37 million, up 101.7% year-over-year; for FY2025, it came in at $63.58 million, up 46.9% from FY2024.

  • Selling, General & Administrative has increased for eight consecutive years, with a five-year compound annual growth rate of 29.6% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $43.28 million in FY2024 (+25.9%), $34.38 million in FY2023 (+31.1%), $26.21 million in FY2022 (+33.5%) and $19.64 million in FY2021 (+12.7%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q1 2017.
  • Year over year, Selling, General & Administrative has now increased in each of the last 18 quarters, with growth averaging 63.1% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q2 2026 (growth of 137.9%); the low point was Q3 2021 (a decline of 10.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $28.24 million (Q1 2026), $23.93 million (Q4 2025) and $14.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Cogent Biosciences 5.32 Bn 5.32 Bn - 31.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.83 Mn
Mar 31, 2026 28.24 Mn
Dec 31, 2025 23.93 Mn
Sep 30, 2025 14.37 Mn
Jun 30, 2025 13.38 Mn
Mar 31, 2025 11.90 Mn
Dec 31, 2024 11.69 Mn
Sep 30, 2024 11.80 Mn
Jun 30, 2024 10.09 Mn
Mar 31, 2024 9.70 Mn
Dec 31, 2023 9.51 Mn
Sep 30, 2023 9.45 Mn
Jun 30, 2023 8.21 Mn
Mar 31, 2023 7.20 Mn
Dec 31, 2022 7.00 Mn
Sep 30, 2022 6.89 Mn
Jun 30, 2022 6.38 Mn
Mar 31, 2022 5.95 Mn
Dec 31, 2021 5.13 Mn
Sep 30, 2021 5.02 Mn
API Access

Cogent Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=COGT&period=max&api_key=YOUR_API_KEY